The aim of this review was to systematically analyze possible procedural risks and pitfalls depending on the underlying disease and provide clinical guidance based on the available literature. Because of the number of coagulation disorders and the lack of data regarding CA in specific disorders, we focused on the most common coagulation disorders, namely heparin-induced thrombocytopenia (HIT), hemophilia, heterozygous Factor V (FV) Leiden mutation, von Willebrand Disease (vWD), light chain amyloidosis, antiphospholipid syndrome, myelodysplastic syndrome, immune-mediated disorders and hereditary hemorrhagic telangiectasia.
MethodsThis systematic review was conducted in accord with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.A systematic search was performed of the PubMed database from inception to April 2019. The search strategy focused on identifying studies and case reports that described electrophysiological procedures in patients with coagulopathies. The reference lists of the included articles and other published reviews were also examined to identify